Mefloquine blockade of connexin 36 and connexin 43 gap junctions and risk of suicide

Biological Psychiatry

Volumn 71, Issue 1, 2012, Pages

  Nevin, Remington L ^a  

^a Bayne Jones Army Community Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; CONNEXIN 36; CONNEXIN 43; GLYCOPROTEIN P; MEFLOQUINE; MULTIDRUG RESISTANCE PROTEIN 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

AMYGDALOID NUCLEUS; CELL COMMUNICATION; CHEMOPROPHYLAXIS; DEPRESSION; DRUG BINDING; GABAERGIC SYSTEM; GAP JUNCTION; GENETIC POLYMORPHISM; HALLUCINATION; HIPPOCAMPUS; HUMAN; HYPOTHALAMUS; INSOMNIA; LETTER; NIGHTMARE; NONHUMAN; PANIC; PARANOIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSYCHOSIS; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SUICIDAL IDEATION; SUICIDE; SYNAPTIC TRANSMISSION; THALAMUS; VENTRAL TEGMENTUM;

ANIMALS; ASTROCYTES; CONNEXIN 43; CONNEXINS; FEMALE; HUMANS; MALE; PREFRONTAL CORTEX; SUICIDE;

EID: 82755197844     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2011.07.026     Document Type: Letter

References (51)

1. C. Ernst, C. Nagy, S. Kim, J.P. Yang, X. Deng, and I.C. Hellstrom Dysfunction of astrocyte connexins 30 and 43 in dorsal lateral prefrontal cortex of suicide completers Biol Psychiatry 70 2011 312 319
2. Dere E, Zlomuzica A (in press): The role of gap junctions in the brain in health and disease. Neurosci Biobehav Rev.
3. P. Lebain, C. Juliard, J.P. Davy, and S. Dollfus [Neuropsychiatric symptoms in preventive antimalarial treatment with mefloquine: apropos of 2 cases] (in French) Encephale 26 2000 67 70
4. N. Jousset, C. Rougé-Maillart, A. Turcant, M. Guilleux, A. Le Bouil, and A. Tracqui Suicide by skull stab wounds: a case of drug-induced psychosis Am J Forensic Med Pathol 31 2010 378 381
5. S.J. Cruikshank, M. Hopperstad, M. Younger, B.W. Connors, D.C. Spray, and M. Srinivas Potent block of Cx36 and Cx50 gap junction channels by mefloquine Proc Natl Acad Sci U S A 101 2004 12364 12369 (Pubitemid 39145449)
6. Nevin, RL (in press): Mefloquine neurotoxicity and gap junction blockade: critical insights in drug repositioning. Neurotoxicology.
7. P. Beck, A. Odle, T. Wallace-Huitt, R.D. Skinner, and E. Garcia-Rill Modafinil increases arousal determined by P13 potential amplitude: an effect blocked by gap junction antagonists Sleep 31 2008 1647 1654
8. E. Garcia-Rill, D.S. Heister, M. Ye, A. Charlesworth, and A. Hayar Electrical coupling: novel mechanism for sleep-wake control Sleep 30 2007 1405 1414 (Pubitemid 350036968)
9. D.W. Allison, A.J. Ohran, S.H. Stobbs, M. Mameli, C.F. Valenzuela, and S.N. Sudweeks Connexin-36 gap junctions mediate electrical coupling between ventral tegmental area GABA neurons Synapse 60 2006 20 31 (Pubitemid 43742954)
10. T. Ohbuchi, T. Yokoyama, T. Saito, J. Ohkubo, H. Suzuki, and T. Ishikura Possible contribution of pannexin channel to ATP-induced currents in vitro in vasopressin neurons isolated from the rat supraoptic nucleus Brain Res 1394 2011 71 78
11. F.J. Urbano, E. Leznik, and R.R. Llinás Modafinil enhances thalamocortical activity by increasing neuronal electrotonic coupling Proc Natl Acad Sci USA 104 2007 12554 12559 (Pubitemid 47206176)
12. S. Bissiere, M. Zelikowsky, R. Ponnusamy, N.S. Jacobs, H.T. Blair, and M.S. Fanselow Electrical synapses control hippocampal contributions to fear learning and memory Science 331 2011 87 91
13. C.E. Gee, P. Benquet, S. Demont-Guignard, F. Wendling, and U. Gerber Energy deprivation transiently enhances rhythmic inhibitory events in the CA3 hippocampal network in vitro Neuroscience 168 2010 605 612
14. L. Chung, and S.D. Moore Neuropeptides modulate compound postsynaptic potentials in basolateral amygdala Neuroscience 164 2009 1389 1397
15. Nevin RL (in press): Hallucinations and Persecutory Delusions in Mefloquine-Associated Suicide. Am J Forensic Med Pathol.
16. G. Ellison The N-methyl-D-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias Brain Res Brain Res Rev 20 1995 250 267
17. J. Dalmau, E. Lancaster, E. Martinez-Hernandez, M.R. Rosenfeld, and R. Balice-Gordon Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis Lancet Neurol 10 2011 63 74
18. T. Marsepoil, J. Petithory, J.M. Faucher, P. Ho, E. Viriot, and F. Benaiche [Encephalopathy and memory disorders during treatments with mefloquine] (in French) Rev Med Interne 14 1993 788 791
19. D.J. Javorsky, G. Tremont, G.I. Keitner, and A.H. Parmentier Cognitive and neuropsychiatric side effects of mefloquine J Neuropsychiatry Clin Neurosci 13 2001 302 (Pubitemid 32499681)
20. M.B. Lassen, J.E. Brown, S.H. Stobbs, S.H. Gunderson, L. Maes, and C.F. Valenzuela Brain stimulation reward is integrated by a network of electrically coupled GABA neurons Brain Res 1156 2007 46 58 (Pubitemid 46920509)
21. S.C. Steffensen, K.D. Bradley, D.M. Hansen, J.D. Wilcox, R.S. Wilcox, and D.W. Allison The role of connexin-36 gap junctions in alcohol intoxication and consumption Synapse 65 2011 695 707
22. D.W. Allison, R.S. Wilcox, K.L. Ellefsen, C.E. Askew, D.M. Hansen, and J.D. Wilcox Mefloquine effects on ventral tegmental area dopamine and GABA neuron inhibition: a physiologic role for connexin-36 gap junctions Synapse 65 2011 804 813
23. J.M. Alisky, E.L. Chertkova, and K.A. Iczkowski Drug interactions and pharmacogenetic reactions are the basis for chloroquine and mefloquine-induced psychosis Med Hypotheses 67 2006 1090 1094 (Pubitemid 44302230)
24. M.V. Bennett, and R.S. Zukin Electrical coupling and neuronal synchronization in the mammalian brain Neuron 41 2004 495 511 (Pubitemid 38253063)
25. N. Rouach, A. Koulakoff, V. Abudara, K. Willecke, and C. Giaume Astroglial metabolic networks sustain hippocampal synaptic transmission Science 322 2008 1551 1555
26. S. Mylvaganam, L. Zhang, C. Wu, Z.J. Zhang, M. Samoilova, and J. Eubanks Hippocampal seizures alter the expression of the pannexin and connexin transcriptome J Neurochem 112 2010 92 102
27. S.H. Fatemi, T.D. Folsom, T.J. Reutiman, T. Pandian, N.N. Braun, and K. Haug Chronic psychotropic drug treatment causes differential expression of connexin 43 and GFAP in frontal cortex of rats Schizophr Res 104 2008 127 134
28. E. Boudreau, B. Schuster, J. Sanchez, W. Novakowski, R. Johnson, and D. Redmond Tolerability of prophylactic Lariam regimens Trop Med Parasitol 44 1993 257 265
29. C.R. Meier, K. Wilcock, and S.S. Jick The risk of severe depression, psychosis or panic attacks with prophylactic antimalarials Drug Saf 27 2004 203 213 (Pubitemid 38315329)
30. M.R. Wallace, T.W. Sharp, B. Smoak, C. Iriye, P. Rozmajzl, and S.A. Thornton Malaria among United States troops in Somalia Am J Med 100 1996 49 55 (Pubitemid 26049326)
31. B.M. Burke Mefloquine Lancet 341 1993 1605 1606
32. F.X. Borruat, B. Nater, L. Robyn, and B. Genton Prolonged visual illusions induced by mefloquine (Lariam): a case report J Travel Med 8 2001 148 149 (Pubitemid 32577649)
33. A. Sowunmi, L.A. Salako, A.M. Oduola, O. Walker, J.A. Akindele, and O.A. Ogundahunsi Neuropsychiatric side effects of mefloquine in Africans Trans R Soc Trop Med Hyg 87 1993 462 463
34. A. Sowunmi Acute psychosis after mefloquine: a case report East Afr Med J 71 1994 818 819
35. R.C. Wittes, and R. Saginur Adverse reaction to mefloquine associated with ethanol ingestion CMAJ 152 1995 515 517
36. A. Sowunmi, R.A. Adio, A.M. Oduola, O.A. Ogundahunsi, and L.A. Salako Acute psychosis after mefloquine Report of six cases Trop Geogr Med 47 1995 179 180
37. Qin P (in press): The impact of psychiatric illness on suicide: Differences by diagnosis of disorders and by sex and age of subjects. J Psychiatr Res.
38. M.R. Nadorff, S. Nazem, and A. Fiske Insomnia symptoms, nightmares, and suicidal ideation in a college student sample Sleep 34 2011 93 98
39. K. Hor, and M. Taylor Suicide and schizophrenia: a systematic review of rates and risk factors J Psychopharmacol 24 suppl 4 2010 81 90
40. G.R. Juszczak, and A.H. Swiergiel Properties of gap junction blockers and their behavioural, cognitive and electrophysiological effects: animal and human studies Prog Neuropsychopharmacol Biol Psychiatry 33 2009 181 198
41. R. Chevli, and C.D. Fitch The antimalarial drug mefloquine binds to membrane phospholipids Antimicrob Agents Chemother 21 1982 581 586 (Pubitemid 12070525)
42. R. Jones, G. Kunsman, B. Levine, M. Smith, and C. Stahl Mefloquine distribution in postmortem cases Forensic Sci Int 68 1994 29 32 (Pubitemid 24292355)
43. R.L. Nevin Epileptogenic potential of mefloquine chemoprophylaxis: a pathogenic hypothesis Malar J 8 2009 188
44. Milner E, Sousa J, Pybus B, Melendez V, Gardner S, Grauer K, et al. (in press): Characterization of in vivo metabolites of WR319691, a novel compound with activity against Plasmodium falciparum. Eur J Drug Metab Pharmacokinet.
45. G.S. Dow, E. Milner, I. Bathurst, J. Bhonsle, D. Caridha, and S. Gardner Central nervous system exposure of next generation quinoline methanols is reduced relative to mefloquine after intravenous dosing in mice Malar J 10 2011 150
46. T. Ishikawa, A. Sakurai, H. Hirano, A. Lezhava, M. Sakurai, and Y. Hayashizaki Emerging new technologies in Pharmacogenomics: rapid SNP detection, molecular dynamic simulation, and QSAR analysis methods to validate clinically important genetic variants of human ABC Transporter ABCB1 (P-gp/MDR1) Pharmacol Ther 126 2010 69 81
47. R. Kerb, R. Fux, K. Mörike, P.G. Kremsner, J.P. Gil, and C.H. Gleiter Pharmacogenetics of antimalarial drugs: effect on metabolism and transport Lancet Infect Dis 9 2009 760 774
48. A.L. Aarnoudse, R.H. van Schaik, J. Dieleman, M. Molokhia, M.M. van Riemsdijk, and R.J. Ligthelm MDR1 gene polymorphisms are associated with neuropsychiatric adverse effects of mefloquine Clin Pharmacol Ther 80 2006 367 374 (Pubitemid 44479754)
49. L.C. Patchen, C.C. Campbell, and S.B. Williams Neurologic reactions after a therapeutic dose of mefloquine N Engl J Med 321 1989 1415 1416 (Pubitemid 19284212)
50. J. Karbwang, and N.J. White Clinical pharmacokinetics of mefloquine Clin Pharmacokinet 19 1990 264 279 (Pubitemid 20283426)
51. E. Schwartz, I. Potasman, M. Rotenberg, S. Almog, and S. Sadetzki Serious adverse events of mefloquine in relation to blood level and gender Am J Trop Med Hyg 65 2001 189 192 (Pubitemid 32847809)